The Journal of Clinical Endocrinology and Metabolism Journal Article

Cancer Outcomes in Prediabetes and T2D With Lifestyle Interventions

September 05, 2023
 

Minghui Zhang, Kelly Pozzer Zucatti, Paula Portal Teixeira, Poliana Espíndola Correia, Laura Fink Wayerbacher, Bernardo F Spiazzi, Mariana P Socal, Edward J Boyko, Verônica Colpani, Fernando Gerchman
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 8, August 2023, Pages 2124–2133
https://doi.org/10.1210/clinem/dgad123

Abstract

Context

People with type 2 diabetes (T2D) have higher risks of cancer incidence and death.

Objective

We aimed to evaluate the relationship between dietary and physical activity-based lifestyle intervention and cancer outcomes among prediabetes and T2D populations.

Methods

We searched for randomized controlled trials with at least 24 months of lifestyle interventions in prediabetes or T2D populations. Data were extracted by pairs of reviewers and discrepancies were resolved by consensus. Descriptive syntheses were performed, and the risk of bias was assessed. Relative risks (RRs) and 95% CIs were estimated using a pairwise meta-analysis with both a random-effects model and a general linear mixed model (GLMM). Certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation framework, and trial sequential analysis (TSA) was conducted to assess if current information is enough for definitive conclusions. Subgroup analysis was performed by glycemic status.

Results

Six clinical trials were included. Among 12,841 participants, the combined RR for cancer mortality comparing lifestyle interventions with usual care was 0.94 (95% CI, 0.81–1.10 using GLMM and 0.82–1.09 using random-effects model). Most studies had a low risk of bias, and the certainty of evidence was moderate. TSA showed that the cumulative Z curve reached futility boundary while total number did not reach detection boundary.

Conclusion

Based on the limited data available, dietary and physical activity–based lifestyle interventions had no superiority to usual care on reducing cancer risk in populations with prediabetes and T2D. Lifestyle interventions focused on cancer outcomes should be tested to better explore their effects.

Read the article

 

You may also like...

Publishing Benefits

Author Resource Center

We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.
Publishing Benefits

Author Resource Center

We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.

Thematic Issue

Latest Thematic Issue

immuno-endocrinology
Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.

Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.